Arkolith/Insider Trading/VIRI/Form 4

Duncan Gregory Scott

Chief Executive Officer, DirectorVirios Therapeutics, Inc. (VIRI) · full profile →Form 4 · filed Apr 7, 2021
Net Buying
Open-Market Buys
$2K
Open-Market Sells
$0
Net Open-Market Flow
$2K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 6, 2021Buy(P)382$6.36$2K20K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-047486) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML